Platelet transfusion in neonatal intensive care units of 22 European countries: a prospective observational study

. 2024 Dec ; 47 () : 101086. [epub] 20241010

Status PubMed-not-MEDLINE Jazyk angličtina Země Velká Británie, Anglie Médium electronic-ecollection

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid39669406
Odkazy

PubMed 39669406
PubMed Central PMC11635195
DOI 10.1016/j.lanepe.2024.101086
PII: S2666-7762(24)00253-9
Knihovny.cz E-zdroje

BACKGROUND: Platelet transfusions are given to preterm infants with severe thrombocytopenia aiming to prevent haemorrhage. The PlaNeT2/MATISSE trial revealed higher rates of mortality and/or major bleeding in preterm infants receiving prophylactic platelet transfusions at a platelet count threshold of 50 × 109/L compared to 25 × 109/L. The extent to which this evidence has been incorporated into clinical practice is unknown, thus we aimed to describe current neonatal platelet transfusion practices in Europe. METHODS: We performed a prospective observational study in 64 neonatal intensive care units across 22 European countries between September 2022 and August 2023. Outcome measures included observed transfusion prevalence rates (per country and overall, pooled using a random effects Poisson model), expected rates based on patient-mix (per country, estimated using logistic regression), cumulative incidence of receiving a transfusion by day 28 (with death and discharge considered as competing events), transfusion indications, volumes and infusion rates, platelet count triggers and increment, and adverse effects. FINDINGS: We included 1143 preterm infants, of whom 71 (6.2%, [71/1143]) collectively received 217 transfusions. Overall observed prevalence rate was 0.3 platelet transfusion days per 100 admission days. By day 28, 8.3% (95% CI: 5.5-11.1) of infants received a transfusion. Most transfusions were indicated for threshold (74.2%, [161/217]). Pre-transfusion platelet counts were above 25 × 109/L in 33.1% [53/160] of these transfusions. There was significant variability in volume and duration. INTERPRETATION: The restrictive threshold of 25 × 109/L is being integrated into clinical practice. Research is needed to explore existing variation and generate evidence for various aspects including optimal volumes and infusion rates. FUNDING: Sanquin, EBA, and ESPR.

2 Department of Neonatology Poznan University of Medical Sciences Poznan Poland

Amsterdam UMC University of Amsterdam Emma Children's Hospital Pediatric Hematology Meibergdreef 9 Amsterdam the Netherlands

Centro Materno Infantil do Norte Unidade Local de Saúde de Santo António Porto Portugal

Charité Universitätsmedizin Berlin Berlin Germany

CHU de Rennes Rennes France

Department of Neonatal and Paediatric Intensive Care Copenhagen University Hospital Rigshospitalet Copenhagen Denmark

Department of Neonatology Semmelweis University Budapest Hungary

Faculty of Health Sciences University of Bristol Bristol United Kingdom

Fondazione IRCCS Policlinico San Matteo Pavia Italy

Jessenius Faculty of Medicine University Hospital Martin Martin Slovakia

Karolinska Institute Stockholm Sweden

La Fe University Hospital Valencia Spain

Leiden University Medical Centre Leiden the Netherlands

Medical University Vienna Vienna Austria

National Maternity Hospital Dublin Ireland

National Perinatal Epidemiology Unit Oxford Population Health University of Oxford Oxford United Kingdom

NHS Blood and Transplant London United Kingdom

Oslo University Hospital Oslo Norway

Sanquin Research Department of Molecular Cellular Hemostasis Amsterdam the Netherlands

Sanquin Research Sanquin Blood Supply Foundation Amsterdam the Netherlands

University College Dublin Dublin Ireland

University Hospital Centre Zagreb University of Zagreb School of Medicine Zagreb Croatia

University Hospital Hradec Králové Hradec Králové Czech Republic

University Hospital Zurich Zurich Switzerland

University Medical Centre Ljubljana Ljubljana Slovenia

University Medical Centre Sarajevo Sarajevo Bosnia and Herzegovina

University of Ljubljana Faculty of Medicine Ljubljana Slovenia

University of Medicine and Pharmacy Iuliu Hatieganu Cluj Napoca Romania

University of Oxford Oxford United Kingdom

UZ Leuven Leuven Belgium

Women's and Children's Division Southmead Hospital North Bristol NHS Trust Bristol United Kingdom

Zobrazit více v PubMed

Curley A., Stanworth S.J., Willoughby K., et al. Randomized trial of platelet-transfusion thresholds in neonates. N Engl J Med. 2019;380(3):242–251. PubMed

Scrivens A., Reibel N.J., Heeger L., et al. Survey of transfusion practices in preterm infants in Europe. Arch Dis Child Fetal Neonatal Ed. 2023;108(4):360–366. PubMed PMC

Stijnen T., Hamza T.H., Ozdemir P. Random effects meta-analysis of event outcome in the framework of the generalized linear mixed model with applications in sparse data. Stat Med. 2010;29(29):3046–3067. PubMed

Davenport P.E., Chan Yuen J., Briere J., Feldman H.A., Sola-Visner M.C., Leeman K.T. Implementation of a neonatal platelet transfusion guideline to reduce non-indicated transfusions using a quality improvement framework. J Perinatol. 2021;41(6):1487–1494. PubMed PMC

Borges J.P., dos Santos A.M., da Cunha D.H., Mimica A.F., Guinsburg R., Kopelman B.I. Restrictive guideline reduces platelet count thresholds for transfusions in very low birth weight preterm infants. Vox Sang. 2013;104(3):207–213. PubMed

Zabeida A., Chartrand L., Lacroix J., Villeneuve A. Platelet transfusion practice pattern before and after implementation of a local restrictive transfusion protocol in a neonatal intensive care unit. Transfusion. 2023;63(1):134–142. PubMed

Bahr T.M., Christensen T.R., Henry E., et al. Platelet transfusions in a multi-neonatal intensive care unit health care organization before and after publication of the PlaNeT-2 clinical trial. J Pediatr. 2023;257 PubMed

Heeger L.E., Houben N.A.M., Caram-Deelder C., Fustolo-Gunnink S.F., van der Bom J.G., Lopriore E. Impact of restrictive platelet transfusion strategies on transfusion rates: a cohort study in very preterm infants. Transfusion. 2024;64(8):1421–1427. PubMed

Sparger K.A., Assmann S.F., Granger S., et al. Platelet transfusion practices among very-low-birth-weight infants. JAMA Pediatr. 2016;170(7):687–694. PubMed PMC

Fustolo-Gunnink S.F., Huisman E.J., van der Bom J.G., et al. Are thrombocytopenia and platelet transfusions associated with major bleeding in preterm neonates? A systematic review. Blood Rev. 2019;36:1–9. PubMed

Baer V.L., Lambert D.K., Henry E., Christensen R.D. Severe thrombocytopenia in the NICU. Pediatrics. 2009;124(6):e1095–e1100. PubMed

Ballabh P. Intraventricular hemorrhage in premature infants: mechanism of disease. Pediatr Res. 2010;67(1):1–8. PubMed PMC

von Lindern J.S., van den Bruele T., Lopriore E., Walther F.J. Thrombocytopenia in neonates and the risk of intraventricular hemorrhage: a retrospective cohort study. BMC Pediatr. 2011;11:16. PubMed PMC

Muthukumar P., Venkatesh V., Curley A., et al. Severe thrombocytopenia and patterns of bleeding in neonates: results from a prospective observational study and implications for use of platelet transfusions. Transfus Med. 2012;22(5):338–343. PubMed

Stanworth S.J., Clarke P., Watts T., et al. Prospective, observational study of outcomes in neonates with severe thrombocytopenia. Pediatrics. 2009;124(5):e826–e834. PubMed

Patel R.M., Hendrickson J.E., Nellis M.E., et al. Variation in neonatal transfusion practice. J Pediatr. 2021;235:92–99.e4. PubMed PMC

van der Staaij H., Stanworth S.J., Fustolo-Gunnink S.F. Prophylactic platelet transfusions: why less is more. Clin Perinatol. 2023;50(4):775–792. PubMed

Moore C.M., D’Amore A., Fustolo-Gunnink S., et al. Two-year outcomes following a randomised platelet transfusion trial in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2023;108(5):452–457. PubMed PMC

Thomas S. Platelets: handle with care. Transfus Med. 2016;26(5):330–338. PubMed

Sahota G., Munir T., Chang C. Platelet transfusions. BMJ. 2011;343

Kalteren W.S., Bos A.F., Bergman K.A., van Oeveren W., Hulscher J.B.F., Kooi E.M.W. The short-term effects of RBC transfusions on intestinal injury in preterm infants. Pediatr Res. 2023;93(5):1307–1313. PubMed PMC

Dannaway D.C., Noori S. A randomized trial of platelet transfusions over 30 vs 120 minutes: is there an effect on post-transfusion platelet counts? J Perinatol. 2013;33(9):703–706. PubMed

Moore C.M., Curley A.E. Neonatal platelet transfusions: starting again. Transfus Med Rev. 2021;35(3):29–35. PubMed

Bassan H. Intracranial hemorrhage in the preterm infant: understanding it, preventing it. Clin Perinatol. 2009;36(4):737–762. PubMed

Honohan A., van’t Ende E., Hulzebos C., et al. Posttransfusion platelet increments after different platelet products in neonates: a retrospective cohort study. Transfusion. 2013;53(12):3100–3109. PubMed

European Commission Directorate-General for Health and Food Safety . 2023. Summary of the 2022 annual reporting of serious adverse reactions and events for blood and blood components.

Strauss R.G. Platelet transfusions in neonates: questions and answers. Expert Rev Hematol. 2010;3(1):7–9. PubMed

Davenport P., Sola-Visner M. Platelet transfusions in neonates: beyond hemostasis. Arterioscler Thromb Vasc Biol. 2023;43(6):886–888. PubMed PMC

McFadyen J.D., Kaplan Z.S. Platelets are not just for clots. Transfus Med Rev. 2015;29(2):110–119. PubMed

Waubert de Puiseau M., Sciesielski L.K., Meyer O., et al. Pooling, room temperature, and extended storage time increase the release of adult-specific biologic response modifiers in platelet concentrates: a hidden transfusion risk for neonates? Transfusion. 2020;60(8):1828–1836. PubMed

Bahr T.M., Snow G.L., Christensen T.R., et al. Can red blood cell and platelet transfusions have a pathogenic role in bronchopulmonary dysplasia? J Pediatr. 2024;265 PubMed

Moore C.M., O’Reilly D., McCallion N., Curley A.E. Changes in inflammatory proteins following platelet transfusion in a neonatal population. Pediatr Res. 2023;94(6):1973–1977. PubMed PMC

Davenport P., Sola-Visner M. Hemostatic challenges in neonates. Front Pediatr. 2021;9 PubMed PMC

O'Reilly D., Murphy C.A., Drew R., et al. Platelets in pediatric and neonatal sepsis: novel mediators of the inflammatory cascade. Pediatr Res. 2022;91(2):359–367. PubMed PMC

Maurya P., Ture S.K., Li C., et al. Transfusion of adult, but not neonatal, platelets promotes monocyte trafficking in neonatal mice. Arterioscler Thromb Vasc Biol. 2023;43(6):873–885. PubMed PMC

Davenport P., Soule-Albridge E., Sola-Visner M. Hemostatic and immunologic effects of platelet transfusions in neonates. Clin Perinatol. 2023;50(4):793–803. PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...